Wednesday, February 1, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosurveillance

U.S. Opens Funding for New Public Health Pathogens Genomics Centers of Excellence

by Global Biodefense Staff
March 20, 2022
U.S. Opens Funding for New Public Health Pathogens Genomics Centers of Excellence

Loretta Bowman, an Oak Ridge Institute for Science and Education fellow with the Army Public Health Center Molecular Biology Method Development Section, loads sterile plasticware on the RNA extraction instrument. Credit: Graham Snodgrass

The Centers for Disease Control and Prevention (CDC) has announced the availability of cooperative agreement funds for this fiscal year to establish the US Pathogen Genomics Centers of Excellence (PGCoE) network.

The Biden Administration initially announced plans for the PGCoE network in July 2021, with the objective to foster innovation in pathogen genomics and molecular epidemiology in order to improve the control of and response to microbial threats of public-health importance.

Standing up the PGCoE will accelerated translation of relevant pathogen genomic technologies and innovations into the US public health system, particularly in public health agencies at the local, state, tribal, territorial and national level; improve training of the public health workforce in microbial genomics and genomic epidemiology; and develop rapid and scalable use of pathogen genomics in responding to public health emergencies from infectious diseases in order to improve detection, characterization, and prevention of infectious disease threats.

The Centers of Excellence network is intended to enable the public health system to better respond to infectious disease threats with resilience, flexibility and the latest practical advances in laboratory technology, scientific computing, and applied research. The funded cooperative agreements will establish several centers of excellence, each consisting of a combination of a health department and one or more academic institutions with the purpose of working together as a network to establish a platform to develop and identify relevant areas of genomics and related technologies, adapt them for use in public health, and pilot their application in actual settings.

The network of health departments with their academic partners is expected to also implement three other high-level strategies: education of the public health workforce, including bioinformaticians, microbiologists, and epidemiologists, preparing to respond to infectious threats, and responding to infectious threats.

Background

Rapid advances in genomic technologies are transforming public health, particularly the prevention and control of infectious diseases. “Next-generation sequencing”, bioinformatics, and genomic epidemiology are improving understanding of pathogen transmission and clinical features including of foodborne illness, tuberculosis, influenza, SARS-CoV-2, and antimicrobial drug resistant organisms. Bringing these advances into everyday public health is a priority and can also present a challenge, especially given the continued rapid evolution of genomics, bioinformatics, and related technologies.

The Pathogen Genomics Centers of Excellence are envisioned to include:

  • Translation: developing, identifying, refining, evaluating, piloting, and implementing technologies and practices relevant to public health
  • Education: developing practical training for public health professionals
  • Response Base: developing capacity to respond to infectious disease threats
  • Responding to infectious disease threats by applying genomic technologies and synthesizing diverse data
  • Lead network educational activities and develop an online training program

The public health agencies will be the prime recipients of their respective awards and are expected to bring deep understanding of public health priorities and practice as well as needs of the public health workforce. The academic centers (sub-recipients) are expected to bring expertise in microbial genomics and genomic epidemiology and access to innovation and novel, relevant technologies. The intent is for these groups to work synergistically together, accelerating the application of genomics and related technologies in public health, focusing initially on the U.S. but with an eye towards making innovations globally accessible. The PGCoE are expected to work together as a network, and with CDC, its programs, and other partners.

The translational strategy will be the main, ongoing focus of the PGCoE network and relies on
developing and identifying technologies and approaches that have relevance for public health,
adapting and evaluating those for use in public health, piloting those in real-life public health
settings and, if applicable, assisting in implementing those in the public health system. In this
sense, the PGCoE network is expected to be a U.S. public health system technology “incubator.”

The educational strategy relies on identifying relevant educational needs of public health bioinformaticians, microbiologists, and epidemiologists and developing training to address these needs. Training that is developed will be mostly online and asynchronous, although some in-person training may also be supported.

US Public Health Pathogens Genomics Centers of Excellence. Centers for Disease Control – National Center for Emerging and Zoonotic Infectious Diseases (NCEZID). Funding Opportunity Number: CDC-RFA-CK22-2204. Estimated Total Program Funding: $185,000,000. Estimated Award Date: 30 September 2022. Original closing date for applications: 17 May 2022.

Tags: Capacity BuildingEditor PickGenomicsInfluenzaOpportunitiesPotential Pandemic PathogensSARS-CoV-2

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
New Virus Discovered in Swiss Ticks
Biosurveillance

New Virus Discovered in Swiss Ticks

December 7, 2022
Why Do Some of the Outbreak Genomes Have More Mutations Than Others?
Biosurveillance

Virginia Institutes Partner to Join National Pathogen Genomics Centers of Excellence Network

October 25, 2022
Researcher holds a pipette
Biodetection

These Nanotech Bubbles Burst When They Detect Viruses in the Air

October 25, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy